London Stock Exchange Group
Go to London Stock Exchange Group Website
Login
 
 
 
Forgotten Password?
 

Email Alert
Email Alert
Company profiles
Company profiles
Annual report
Annual report
Add to Portfolio or Watchlist
Add to Portfolio or Watchlist

GWP  GW PHARMACEUTICALS PLC  ORD 0.1P
GW PHARM.  Currency GBX 

Company

Price +/- % +/- Bid Offer Volume High Low Last close
93.00 -1.00 -1.06% 90.50 93.00 112,820 94.50 90.11 93.00 on 20-Nov-2009
As at 21-Nov-2009 09:28:18 - All data delayed by at least 15 minutes.
This company is quoted on  Market

Share price performance

Last 5 trades
More
Time/Date Price Volume Trade value Type
16:35:21  20-Nov-09 93.00 949 882.57 UT
15:55:20  20-Nov-09 90.31 7,000 6,321.98 O
13:51:00  20-Nov-09 90.11 11,361 10,236.94 OK
13:36:17  20-Nov-09 90.85 4,000 3,633.92 O
11:55:45  20-Nov-09 94.00 10,000 9,400.00 OK

Trading Information
21-Nov-2009
FTSE index FTSE AIM All-Share,FTSE AIM 100,FTSE AIM UK 50,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment AMSM
MiFID Status MTF
Exchange market size 5,000
SEDOL 3054468
ISIN number GB0030544687


Company Fundamentals
More
Interim (£m) 2008 (£m) 2007 (£m) 2007 (£m) 2006 (£m) 2005 (£m)
Currency GBP GBP GBP GBP GBP GBP
Total op. expenses -12.16 -22.78 -19.59 -19.24 -16.85 -12.99
P/L for the financial year 4.03 -8.22 -10.94 -10.59 -11.92 -7.52
Retained profit/loss 4.03 -8.22 -10.94 -10.59 -11.92 -7.52
Total assets 28.15 23.45 30.25 30.61 31.07 22.11
Total liabilities -28.15 -23.45 -30.25 -30.61 -31.07 -22.11

Latest news stories
More
Time/Date Headline
12:15 04-Nov-09    Notice of Results
16:43 30-Oct-09    Blocklisting Interim Review
15:41 30-Oct-09    Total Voting Rights
16:40 17-Sep-09    Second Price Monitoring Extn
16:35 17-Sep-09    Price Monitoring Extension

Company Information
Updated Monthly
Company address Porton Down Science Park, Salisbury, SP4 0JQ, United Kingdom
Company website http://www.gwpharm.com
Market cap(in millions)* £ 120.24
Listing/Admission to trading 28 Jun 2001
Trading system SETS
Market AIM
Activities A group engaged in the research & development of cannabinoid prescription medicines to meet patient needs in a wide range of medical conditions
Auditor Deloitte Touche Tohmatsu
Financial Advisor N M Rothschild Ltd, Investec Plc
Broker Investec Plc
Solicitor Mayer Brown Rowe & Maw LLP
Registrar Capita IRG Plc

*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are subject to change. Last updated: 20-Nov-2009



GW PHARM. price